These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8818040)
21. [(186/188)Re] rhenium-ethylene dicysteine (Re-Ec): preparation and evaluation for possible use in endovascular brachytherapy. Das T; Banerjee S; Samuel G; Kothari K; Unni PR; Sarma HD; Ramamoorthy N; Pillai MR Nucl Med Biol; 2000 Feb; 27(2):189-97. PubMed ID: 10773549 [TBL] [Abstract][Full Text] [Related]
22. SPECT image analysis using statistical parametric mapping: comparison of technetium-99m-HMPAO and technetium-99m-ECD. Patterson JC; Early TS; Martin A; Walker MZ; Russell JM; Villanueva-Meyer H J Nucl Med; 1997 Nov; 38(11):1721-5. PubMed ID: 9374340 [TBL] [Abstract][Full Text] [Related]
23. A rapid chromatographic method for quality control of technetium-99m-bicisate. Amin KC; Saha GB; Go RT J Nucl Med Technol; 1997 Mar; 25(1):49-51. PubMed ID: 9239604 [TBL] [Abstract][Full Text] [Related]
24. Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis. O'Brien TJ; Brinkmann BH; Mullan BP; So EL; Hauser MF; O'Connor MK; Hung J; Jack CR J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):331-9. PubMed ID: 10084532 [TBL] [Abstract][Full Text] [Related]
25. [Phase I clinical study of 99mTc-ECD]. Kubo A; Nakamura K; Tsukatani Y; Sanmiya T; Shimizu S; Yokoyama K; Hashimoto S; Torizuka K Kaku Igaku; 1992 Aug; 29(8):1019-27. PubMed ID: 1434082 [TBL] [Abstract][Full Text] [Related]
28. Use of high performance liquid chromatography for the structural identification of technetium-99m radiopharmaceuticals at the NCA level. Baldas J; Bonnyman J; Ivanov Z J Nucl Med; 1989 Jul; 30(7):1240-8. PubMed ID: 2738705 [TBL] [Abstract][Full Text] [Related]
29. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC. Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640 [TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of 99mTc ethyl cysteinate dimer SPECT in patients with spinocerebellar degeneration; comparison with cerebral blood flow determined by PET]. Oriuchi N; Tanaka M; Igarashi H; Watanabe N; Tateno M; Inoue T; Tomiyoshi K; Hirano T; Endo K; Hirai S Kaku Igaku; 1992 Jun; 29(6):659-65. PubMed ID: 1640650 [TBL] [Abstract][Full Text] [Related]
31. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans. Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314 [TBL] [Abstract][Full Text] [Related]
32. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. Vallabhajosula S; Zimmerman RE; Picard M; Stritzke P; Mena I; Hellman RS; Tikofsky RS; Stabin MG; Morgan RA; Goldsmith SJ J Nucl Med; 1989 May; 30(5):599-604. PubMed ID: 2497233 [TBL] [Abstract][Full Text] [Related]
34. [A fundamental study of 99mTc-ethyl cysteinate dimer (99mTc-ECD)]. Mimura H; Ono S; Yanagimoto S; Tomomitsu T; Nishimura F; Muranaka A; Morita K; Nagai K; Otsuka N; Fukunaga M Kaku Igaku; 1992 Oct; 29(10):1227-36. PubMed ID: 1464963 [TBL] [Abstract][Full Text] [Related]
35. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe. Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the renal dynamic scan performed with 99mTc-L,L-EC and 99mTc-MAG3 in children with pelviureteric junction obstruction. Jain V; Arora S; Passah A; Mani K; Yadav DK; Goel P; Gupta DK Nucl Med Commun; 2018 Nov; 39(11):1053-1058. PubMed ID: 30169343 [TBL] [Abstract][Full Text] [Related]
37. Effect of cyclodextrin complexation on the in vivo disposition of the brain imaging radiopharmaceutical 99mTechnetium ethyl cysteinate dimer (99mTc-ECD). Oliver DW; Dormehl IC; Louw W; Kilian E; de Beco V; Morretti JL Arzneimittelforschung; 2000 Aug; 50(8):758-64. PubMed ID: 10994161 [TBL] [Abstract][Full Text] [Related]
38. Preparation and biological evaluation of (99m) TcN-labeled pteroyl-lys derivative as a potential folate receptor imaging agent. Chen Y; Guo H; Xie F; Lu J J Labelled Comp Radiopharm; 2014 Jan; 57(1):12-7. PubMed ID: 24448741 [TBL] [Abstract][Full Text] [Related]
39. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death. Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838 [TBL] [Abstract][Full Text] [Related]
40. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]